TGen's Drug Development Group to Use Mission3 Product-Lifecycle Software

Aug 15, 2007

NEW YORK (GenomeWeb News) - The Translational Genomics Research Institute’s TD2 drug-development arm has agreed to use product-lifecycle software from Mission3, the organizations said recently.

TD2 will use the company’s MissionFire and FastCrossing software to help manage its drug development process.

FastCrossing is a graphical, web-based tool used in application submissions, while MissionFire is used in document and project management.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

The Scan

Embryos Edited in US

Technology Review reports that researchers in the US have used CRISPR to modify a number of human embryos.

True Blue

By introducing genes from butterfly peas and Canterbury bells, researchers in Japan have developed a blue chrysanthemum, according to NPR.

All the Plants

Plant researchers plan to sequence some 10,000 samples that represent the major plant clades, ScienceInsider reports.

This Week in Nature

In Nature this week: a Danish reference genome, and more.

Main menu